View Clinical Trial (Medical Research Study)
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches - NCT00660192-06520(Clinical Trial 215801)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
New Haven |
|
State:
|
|
CT |
| Zip Code: |
|
06520 |
| Conditions: |
|
Refractory Migraine |
| Purpose: |
|
The hypothesis of this study is that injection of botulinum toxin A into the muscles around
the head (frontal, temporal, posterior neck, occipital) can reduce the intensity and
frequency of migraine headaches by 50% and more and this effect is even more positive after
second treatment.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Adults 18 and older
- Migraine for more than three months, that fail to respond to two or more major
anti-migraine drug, meeting criteria of chronic migraine
Exclusion Criteria:
- Age below 18
- Pregnant or may become pregnant
- Disease of neuromuscular junction or drugs that affect N-M junction
- Allergy to Botox
- Previous use of Botox for migraine by similar methodology |
|
|
|
| Study is available at: |
|
Yale Neurology Clinic, 6C, 40 Temple Street
New Haven, CT 06520
United States
Primary Contact:
Diana Richardson, M.D.
Email: diana.richardson@yale.edu
Phone: (203) 737-1831 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|